Skip to main content

Table 3 Overview of recurrent CGH findings in seven thyroid carcinoma cell lines

From: Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples

 

Frequency

SRO

Gains

  

5p

6/7

5p12p15

5q

6/7

5q22q35

8q

6/7

8q11q24

20q

6/7

20q12q13

11p

4/7

11p12p15

17q

4/7

17q21q24

Losses

  

8p

4/7

8p22p23

13q

4/7

13q12q21

13q32q34

18q

4/7

18q12q22

Xp

4/7

Xp11p21

Amp

  

8q

4/7

8q11q23

20q

3/7

20q11q13

5p

2/7

5p12p15

5q

2/7

5q23q33

7pq

2/7

7p22q36

20p

2/7

20p11p13

  1. For gains and losses, only regions seen in more than 3 cell lines are provided. Abbreviations: SRO, smallest region of overlap; Amp, amplifications.